Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia-Reference-Cited by-同舟云学术

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

Published:2017-06-05 Issue:9 Volume:52 Page:1253-1260
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Zhang R,Shi W,Wang H-F,You Y,Zhong Z-D,Li W-M,Zhang C,Lu X,Wang Y-D,Zheng P,Fang J,Hong M,Wu Q-L,Xia L-H

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2017100.pdf

Reference42 articles.

1. Yahng SA, Kim JH, Jeon YW, Yoon JH, Shin SH, Lee SE et al. A well-tolerated regimen of 800cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia. Biol Blood Marrow Transplant 2015; 21: 119–129.

2. Ciurea SO, Bayraktar UD . “No donor”? Consider a haploidentical transplant. Blood Rev 2015; 29: 63–70.

3. Xuan L, Fan Z, Zhang Y, Zhou H, Huang F, Dai M et al. Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT. Oncotarget 2016; 7: 32579–32591.

4. Kawashima N, Inamoto Y, Sato T, Nakashima M, Kagaya Y, Watakabe K et al. Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy. Bone Marrow Transplant 2016; 51: 869–871.

5. Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D et al. Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective comparative study. Leuk Res 2016; 46: 61–68.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation;Cell Transplantation;2024-01

2. Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission;Cancer Medicine;2024-01

3. Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia;Leukemia & Lymphoma;2023-09-21

4. Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk;Transplantation Proceedings;2023-09

5. Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia and myelodysplastic syndrome;Current Research in Translational Medicine;2023-01